Group One Trading, L.P. Astrazeneca PLC Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $83,061 - $94,684	1,361 New	1,361 $92,000
Q2 2021 Aug 10, 2021	SELL	$48.42 - $60.18 $3.84 Million - $4.78 Million	-79,408 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$47.16 - $54.44 $1.64 Million - $1.89 Million	-34,691 Reduced 30.4%	79,408 $3.95 Million
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $3.72 Million - $4.45 Million	76,722 Added 205.27%	114,099 $5.7 Million
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $1.98 Million - $2.28 Million	37,377 New	37,377 $2.05 Million
Q2 2019 Aug 09, 2019	SELL	$37.28 - $41.68 $500,521 - $559,595	-13,426 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$35.49 - $43.02 $476,488 - $577,586	13,426 New	13,426 $543,000
Q1 2018 May 11, 2018	SELL	$32.97 - $36.63 $876,441 - $973,735	-26,583 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$32.09 - $34.78 $853,048 - $924,556	26,583 New	26,583 $922,000
Q3 2017 Nov 15, 2017	SELL	$28.96 - $34.0 $1.96 Million - $2.31 Million	-67,820 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	67,820	67,820 $2.31 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.